protein-based neuropathy therapeutics (Rinat)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameprotein-based neuropathy therapeutics (Rinat)
Drug Alias NameRI-109RI-724RN-205RI-1024RI-205 +[9] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNerve growth factor receptors agonistsNeuroprotectants
TargetsNerve growth factor receptors
Therapy Area/IndicationsNeuralgiaDiabetic NeuropathiesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRinat-Pfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRinat-Pfizer Inc
Active IndicationsN/A
Inactive IndicationsNeuralgiaDiabetic NeuropathiesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A